| Income Statement |
| Operating Expenses | 3.44M |
|
| Research and Development Expense | 2.25M |
| Selling, General and Administrative Expense | 1.19M |
| Operating Income | -3.44M |
| Income Tax Expense | -333.00K |
| Net Income | -3.08M |
| Net Income Common Stock | -3.08M |
| Net Income Common Stock (USD) | -4.11M |
| Consolidated Income | -3.08M |
| Earning Before Interest & Taxes (EBIT) | -3.41M |
| Earning Before Interest & Taxes (USD) | -4.55M |
| Weighted Average Shares | 20.81B |
| Balance Sheet |
| Cash and Equivalents | 19.50M |
| Cash and Equivalents (USD) | 26.00M |
| Current Assets | 22.83M |
| Property, Plant & Equipment Net | 622.00K |
| Total Assets | 25.78M |
| Debt Current | 35.00K |
| Total Debt | 672.00K |
| Current Liabilities | 4.83M |
| Debt Non-Current | 637.00K |
| Total Liabilities | 5.52M |
| Accumulated Retained Earnings (Deficit) | -253.75M |
| Shareholders Equity | 20.26M |
| Shareholders Equity (USD) | 27.01M |
| Assets Non-Current | 2.95M |
| Total Debt (USD) | 896.00K |
| Goodwill and Intangible Assets | 2.21M |
| Liabilities Non-Current | 695.00K |
| Trade and Non-Trade Payables | 450.00K |
| Tax Assets | 2.62M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 71.00K |
| Net Cash Flow from Financing | 51.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.91M |
| Issuance (Purchase) of Equity Shares | 206.00K |
| Issuance (Repayment) of Debt Securities | -20.00K |
| Net Cash Flow from Investing | 103.00K |
| Net Cash Flow from Operations | -2.06M |
| Effect of Exchange Rate Changes on Cash | -117.00K |
| Share Based Compensation | 907.00K |